Taro Pharma (TARO) Reports Q2 EPS of $3.11
Get Alerts TARO Hot Sheet
Join SI Premium – FREE
Taro Pharma (NYSE: TARO) reported Q2 EPS of $3.11, versus $3.35 reported last year. Revenue for the quarter came in at $212.1 million, versus $250.8 million reported last year.
For earnings history and earnings-related data on Taro Pharma (TARO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Midday movers: RH, Estee Lauder rise; Tesla falls
- Forian Inc. (FORA) Tops Q4 EPS by 3c, provides outlook
- Volcon (VLCN) Reports 2023 Operational and Financial Results
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!